Healio

Xen gel stent reduces IOP with fewer adverse events than trabeculectomy

Please provide your email address to receive an email when new articles are posted on . MONTEREY, Calif. — Fewer adverse events overall were reported in eyes receiving Allergan’s Xen gel stent to ...
Business Wire

XEN Gel Stent Receives Approval from Health Canada to Treat Glaucoma

ALISO VIEJO, Calif.--(BUSINESS WIRE)--AqueSys, Inc., the developer of minimally invasive stent technology for the treatment of glaucoma, announced today that the company received a Class 3 Medical ...
Healio

‘Air Xen’ technique offers alternative way to implant gel stent

Please provide your email address to receive an email when new articles are posted on . Since the Xen gel stent was FDA approved in 2016, this less invasive glaucoma surgical device has been widely ...
Business Wire

World Glaucoma Congress to Feature Symposium on XEN Gel Stent for Minimally Invasive IOP Reduction

ALISO VIEJO, Calif.--(BUSINESS WIRE)--AqueSys, Inc., the developer of minimally invasive stent technology for the treatment of glaucoma, announced today it will host a XEN Gel Stent Symposium at the 6 ...
Becker's ASC

Williamson Eye Center hosts Louisiana’s 1st Xen Gel Stent procedure: 5 key notes

Blake Williamson, MD, performed the first Xen Gel Stent procedure form Allergan Surgical in Louisiana at the Williamson Eye Center in Baton Rouge, according to a Weekly Citizen report. 1. The Xen Gel ...
Business Insider

USC Roski Eye Institute ophthalmologists are first to use XEN® gel stent to treat glaucoma patients in Los Angeles

LOS ANGELES, March 14, 2017 /PRNewswire-USNewswire/ -- As a national leader in innovative ophthalmology treatments that prevent blindness the University of Southern California (USC) Roski Eye ...
Nasdaq

China Gives Greenlight to Allergan's XEN® Registration for the Surgical Management of Refractory Glaucoma

DUBLIN, April 2, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced China's National Medical Products Administration (NMPA) approved the registration of Allergan's XEN® Gel Stent on March ...
Nasdaq

AGN : China Oks XEN Registration For Surgical Management Of Refractory Glaucoma

(RTTNews) - Allergan plc (AGN) said that China's National Medical Products Administration approved the registration of the company's XEN Gel Stent for the surgical management of patients with ...
The American Journal of Managed Care

Improving Glaucoma Outcomes With New Technologies and Patient-Centered Care

SLT is emerging as a cost-effective first-line treatment, offering superior intraocular pressure stability compared to traditional eye drops. Minimally invasive glaucoma surgeries, like the iStent ...
Medindia

Allergan Receives FDA Clearance for the XEN Gel Stent, a New Surgical Treatment for Refractory Glaucoma

-- An Ab Interno Approach to Reduce Intraocular Pressure in Patients with Refractory Glaucoma - In the U.S. pivotal trial conducted in refractory glaucoma patients, XEN reduced IOP from a mean ...
Becker's ASC

Ophthalmologist recognized for completion of 100 Xen gel stent implants

Robert Friedman, MD, was recently awarded a certificate of recognition for performing more than 100 Xen Gel Stent procedures, according to a Sept. 3 LinkedIn post from Eye Health America. Dr. Friedman ...